EN | DE

SHARE THIS PAGE:

OPTIMIZING DISCECTOMY OUTCOMES IN HIGH RISK PATIENTS

Although discectomy surgery is generally considered a successful treatment, large population-based studies show a high failure rate over time1,2,3. In particular patients that have tall discs in combination with a large anular defect, confront surgeons with a dilemma: either perform a limited nucleotomy with increased risk of recurrent disc herniation, or a more aggressive nucleotomy with increased risk of disc collapse and chronic back pain over time.

Those patients may benefit from Barricaid® Anular Closure treatment. Barricaid offers surgeons an option to perform a limited nucleotomy in every patient, while closing the anulus in those patients that are left with a large anular defect following surgery.

1 Strömqvist, et al.The Swedish Spine Register: development, design and utility. Eur Spine J. (2009) Aug;18 Suppl 3:294-304.
2 Martin et al. Repeat surgery after lumbar decompression for herniated disc: the quality implications of hospital and surgeon variation. 2 Spine J. 2012 Feb;12(2):89-97. doi: 10.1016/j.spinee.2011.11.010. 
3 Keskimäki et al. Reoperations After Lumbar Disc Surgery. SPINE (2000) Volume 25, Number 12, pp 1500–1508

READ MORE

DISCECTOMY DILEMMA

The Barricaid® device, designed to close large defects in the anulus, allows surgeons to walk away from having to perform an aggressive discectomy in patients at high risk of recurrent herniation.


READ MORE

ABOUT BARRICAID®

Barricaid is designed to close large defects in the anulus to prevent recurrent disc herniation and subsequent reoperations, while allowing the surgeon to preserve the patient’s disc.


READ MORE
Barricaid-clinical-results

CLINICAL RESULTS

Clinical experience with Barricaid spans over 8 years, including one of the largest level I superiority RCTs in spine, where Barricaid has been compared to the gold standard, discectomy alone.


READ MORE